Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 3061-3070 of 10954

Edit search filters
  1. Ga-DOTATATE PET for Localization of Phosphaturic Mesenchymal Tumors in Patients with Tumor Induced Osteomalacia

    Rochester, MN

  2. Neuroimaging Study

    Jacksonville, FL, Rochester, MN

  3. Recurrent Clostridium Difficile vs Post Infectious IBS: A Prospective Study

    Rochester, MN

  4. Penile Length Restoration in Men with Type II Diabetes

    Rochester, MN

  5. Effect of 12-Week Vegetarian Diet Intervention on Inflammatory Status and Cardio-Metabolic Parameters

    Rochester, MN

  6. Mindfulness Intervention for Post-Covid Symptoms

    Rochester, MN

  7. Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients

    Rochester, MN

  8. A Study of ABC294640 (Yeliva®) in the Treatment of Patients with Advanced Cholangiocarcinoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis

    Rochester, MN

  10. Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Monoclonal Antibody Ch14.18 in Treating Younger Patients with Refractory or Relapsed Neuroblastoma

.

Mayo Clinic Footer